Related Experiment Video

Updated: May 4, 2026

Murine Full-thickness Skin Transplantation
07:59

Murine Full-thickness Skin Transplantation

Published on: January 2, 2017

20.1K

Neurotoxicity of immunosuppressive therapies in organ transplantation

Daniela Anghel1, Radu Tanasescu2, Ana Campeanu3

  • 1"Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania ; Fundeni Clinical Institute, Department of Neurology, Bucharest, Romania.

Maedica
|December 28, 2013
PubMed

Insights

Immunosuppressive drugs prevent graft rejection but can cause neurotoxicity in transplant patients. Early recognition of these neurological side effects is crucial for effective treatment and improved patient outcomes.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Transplantation Medicine

Background:

  • Immunosuppressive agents are vital in preventing organ transplant rejection.
  • These medications, including cyclosporine and tacrolimus, can cause significant side effects.
  • Drug-induced neurotoxicity presents diagnostic challenges due to overlapping symptoms with other disorders.

Purpose of the Study:

  • To review the clinical manifestations of neurotoxicity induced by immunosuppressive drugs in transplant recipients.
  • To highlight the importance of early identification and diagnosis of these neurological complications.
  • To discuss the impact of neurotoxicity on patient prognosis and treatment strategies.

Main Methods:

  • Literature review focusing on clinical studies and case reports.
  • Analysis of documented neurotoxic effects associated with common immunosuppressive agents.
  • Synthesis of information on diagnostic challenges and therapeutic considerations.

Main Results:

  • Immunosuppressive drugs can lead to a spectrum of neurological complications in transplant patients.
  • Symptoms of neurotoxicity may be masked by the patient's overall clinical condition and metabolic changes.
  • The specific type of neurotoxic complication influences treatment decisions and patient prognosis.

Conclusions:

  • Prompt recognition of immunosuppressive drug-induced neurotoxicity is essential for optimal management of transplant patients.
  • Understanding the diverse clinical entities of neurotoxicity aids in timely intervention.
  • Effective management strategies depend on accurate diagnosis and consideration of the specific causative agent.
Keywords:
immunosuppressive drugsneurotoxicityposttransplant states

More Related Videos

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation11:49

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation

Published on: May 2, 2013

15.5K
Investigating the Immunological Mechanisms Underlying Organ Transplant Rejection05:10

Investigating the Immunological Mechanisms Underlying Organ Transplant Rejection

Published on: August 20, 2007

5.7K

Related Concept Videos

Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
1.4K
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
64.7K
Drug Toxicity: Dose-Dependent Reactions01:24

Drug Toxicity: Dose-Dependent Reactions

Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
229
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
827
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
631
Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial...
209